The tender covers anesthesia and intensive care supplies. The agreement runs for 2 years with an option of another 2 years. Value on an annual basis is approximately 0.9 MSEK.
Delivery will start on June 1st, 2017.
- Femklövern is one of our major customers. We are pleased and grateful for the continued confidence, says Rikard Akhtarzand, CEO of ADDvise Group.
For further information, please contact: Rikard Akhtarzand, CEO +46 765-25 90 71 email@example.com
This information is by ADDvise required to disclose under the EU Market Abuse Regulation. The information was submitted for publication on December 5th, 2016 at 11:15 CET.
About ADDvise Group ADDvise Group AB (publ) is a leading supplier of equipment to healthcare and research facilities. The group consists of approximately 10 subsidiaries organized into two business areas, Lab and Healthcare. Sales are global. The Group has a clear acquisition strategy with the aim of raising shareholder value and expand the business – both geographically and product wise. The Group has sales of about 250 MSEK. ADDvise shares are listed on Nasdaq First North Premier and Mangold Fondkommission AB, 08-503015 50, is the Company's Certified Adviser. Additional information is available at www.addvisegroup.com.